Literature DB >> 11923170

Case of cholestatic hepatitis with celecoxib did not fulfil international criteria.

Felix M Arellano, Sean Z Zhao, Matthew W Reynolds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923170      PMCID: PMC1122719          DOI: 10.1136/bmj.324.7340.789/a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Drug Points: Cholestatic hepatitis in association with celecoxib.

Authors:  J P O'Beirne; S R Cairns
Journal:  BMJ       Date:  2001-07-07

2.  A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.

Authors:  L A García Rodríguez; A Ruigómez; H Jick
Journal:  Pharmacotherapy       Date:  1997 Jul-Aug       Impact factor: 4.705

3.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

4.  The role of non-steroidal anti-inflammatory drugs in acute liver injury.

Authors:  L A García Rodríguez; S Pérez Gutthann; A M Walker; L Lueck
Journal:  BMJ       Date:  1992-10-10
  4 in total
  2 in total

1.  Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study.

Authors:  Deborah Layton; Lynda V Wilton; Saad A W Shakir
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

2.  Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.

Authors:  Deborah Layton; Patrick C Souverein; Eibert R Heerdink; Saad A W Shakir; Antoine C G Egberts
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.